Companies

Vivos Therapeutics, Inc.

VVOS · CIK 0001716166 · operating

$1.44+2.62%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$16.10M
P/E
Fwd P/E-1.13
PEG
P/S0.93
P/B4.61
EV/EBITDA-1.44
EV/Rev1.27

Profitability

Gross Margin60.00%
Op. Margin-74.32%
Net Margin-74.09%
ROE-140.01%
ROA-72.86%
FCF Margin-88.21%

Financial Health

Current Ratio1.50
Debt/Equity0.92
Free Cash Flow-$13.26M
Div. Yield

Growth & Other

Revenue Growth8.91%
EPS Growth80.07%
Beta6.89
52W High$7.95
52W Low$1.32

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (VVOS) is a surgical & medical instruments & apparatus company incorporated in DE, listed on the Nasdaq. With a market capitalization of $17 million, Vivos Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.44, up 2.62% today, with a 52-week range of $1.42–$7.95.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-2.22$-2.22+80.1%
2023$-11.14$-11.14-971.2%
2022$-1.04
2021
2020

Latest News

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-03-310001641172-25-001750SEC ↗
2023-12-312024-03-280001493152-24-011755SEC ↗
2022-12-312023-03-300001493152-23-009765SEC ↗
2021-12-312022-03-310001493152-22-008452SEC ↗
2020-12-312021-03-250001493152-21-006806SEC ↗